Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Opioid Use Disorder · Methadone · Cannabis · Fentanyl

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Josie Kanu, BSc) · josie.kanu@bccsu.ubc.ca · 6045001102
    Contact: Study coordinator (M. Eugenia Socias, MD, MSc) · eugenia.socias@bccsu.ubc.ca
    Contact: Principal Investigator (Sukhpreet Klaire, MD CCFP (AM)
Study leads
  • M Eugenia Socias, MD, MSc.

    Principal Investigator

    Assistant Professor, Department of Medicine, University of British Columbia